Shijiazhuang Yiling Pharmaceutical Co., Ltd.
SHZ: 002603.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Xiang Jun Wu
- Employees
- 11,708
- Headquarters
- Shijiazhuang, China
- IPO year
- 2011
- Market cap
- CN¥29.0B
- Website
- https://www.yiling.cn
Loading 002603…
Loading profile data…Frequently asked questions about 002603
What does Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) do?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated r...
Where does 002603.SZ trade?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002603.SZ in?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shijiazhuang Yiling Pharmaceutical Co., Ltd.?
Xiang Jun Wu is the chief executive officer of Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ).
Where is Shijiazhuang Yiling Pharmaceutical Co., Ltd. headquartered?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. is headquartered in China.
Does 002603.SZ pay a dividend?
Yes — Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) paid a trailing twelve-month dividend of CNY 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002603.SZ go public?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) completed its initial public offering in 2011.